AOD-9604
Also known as: Anti-Obesity Drug 9604
AOD-9604 is a 16-amino-acid synthetic peptide corresponding to the C-terminal fragment of human growth hormone (residues 177-191) with an additional N-terminal tyrosine. Developed by Metabolic Pharmaceuticals (Australia) to isolate a purported 'lipolytic' activity of GH without GH-receptor-mediated growth or diabetogenic effects. AOD-9604 is NOT FDA-approved for any indication; controlled human trials for obesity did not demonstrate clinically meaningful weight loss, and obesity development was terminated in 2007.
Who's worth your money for AOD-9604
Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.
Top Merit pick
Highest Merit Score (99) of 29 scored sellers
$92.99 · 10mg · 99.7% purity
Best value after code
$0.07/mg effective with 15% code
$0.40 · 5mg · 99.1% purity
Most tested
12 independent COAs on file
$29.40 · 5mg · 99.9% purity
Average price
$10.88/mg
Sellers
79
45-day trend
+12.8%
64 of 79 sellers have a current price· 26 stale hidden· 9 unverified hidden
Top Merit pick
🇺🇸 Glacier Aminos99✓ verified at source · just now
$9.30/mg -14.6% vs avg$92.99
10mg
- 🇺🇸 Hydro Research Peptides97
✓ verified at source · just now
$0.08/mg -99.3% vs avg$0.40
5mg
- 🇺🇸 Moglabs96
✓ verified at source · just now
$7.20/mg -33.8% vs avg$36.00
5mg
- 🇺🇸 Prime Peptides95
✓ verified at source · just now
$12.00/mg +10.3% vs avg$60.00
5mg
- 🇺🇸 Peptide Crafters94
✓ verified at source · just now
$8.07/mg -25.8% vs avg$80.75
10mg
- Nova Peptides94
✓ verified at source · just now
$10.00/mg -8.1% vs avg$49.99
5mg
- 🇺🇸 Polaris Peptides90
✓ verified at source · just now
$20.00/mg +83.8% vs avg$40.00
2mg
no purity - 🇺🇸 Peptidology89
✓ verified at source · just now
$4.50/mg -58.7% vs avg$44.99
10mg
- 🇺🇸 Soma Peptides89
✓ verified at source · just now
$8.90/mg -18.2% vs avg$89.00
10mg
- 🇺🇸 Ruo Bio88
✓ verified at source · just now
$7.60/mg -30.2% vs avg$38.00
5mg
Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.
Watch AOD-9604
Get one email when the market actually moves — no newsletter, no noise.
About AOD-9604
CAS
221231-10-3
Molecular formula
C78H123N23O23S2
Sequence
YLRIVQCRSVEGSCGF
Typical dose range
250–500 mcg/day subcutaneous (research use)
Half-life
~2–3 hours (human); ~3–4 minutes (rat IV, per pharmacokinetic studies)
COAs for AOD-9604
145 third-party tests across 40 vendors. Each card links to the full report.
For
AOD-9604
by OROS Research· batch OR-LPAOD5-726-B4
For
AOD-9604
by Peptide Plugs· batch 160-142L-DK
For
AOD-9604
by Peptide Plugs· batch 155-01-DK
For
AOD-9604
by NG Peptide· batch AD05-06
For
AOD-9604
by NG Peptide· batch AD05-06
For
AOD-9604
by Ion Peptide· batch AD10-06172026
For
AOD-9604
by Ion Peptide· batch AD10-06172026
For
AOD-9604
by Peptide Crafters· batch PC-S-AOD
For
AOD-9604
by Verified Peptides· batch AOD06260905I
For
AOD-9604
by Peptide Supply Co.· batch AOD10 06032026
For
AOD-9604
by EZ Peptides· batch EZP-AOD205242026-04
For
AOD-9604
by EZ Peptides· batch EZP-AOD205242026-04
For
AOD-9604
by OROS Research· batch OR-LPAOD5-326-B3
For
AOD-9604
by Crush Research· batch R-AOD-5-2605-1
For
AOD-9604
by Prime Peptides· batch 4132026AD
For
AOD-9604
by Blank Peptides· batch BP-3713888-P
For
AOD-9604
by Ion Peptide· batch AOD5-05142026
For
AOD-9604
by Sports Technology Labs· batch 2026-05-04
For
AOD-9604
by Skye Peptides· batch AOD26-06-002
For
AOD-9604
by Pepsgpt· batch P-3713888-P
For
AOD-9604
by Ion Peptide· batch AOD5-05042026
For
AOD-9604
by Voltera Sciences· batch AOD5.05.02.2026
For
AOD-9604
by Ion Peptide· batch AOD10-05042026
For
AOD-9604
by Ion Peptide· batch COA-2026-B2XTQX
14 citations indexed for AOD-9604
review · 2026
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Therapeutic peptides are emerging as promising adjuncts in the management of orthopaedic injuries, grounded in their ability to modulate molecular signaling networks central to cellular medicine.
review · 2026
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated injury recovery and performance enhancement.
review · 2026
Annual Banned-Substance Review 18th Edition-Analytical Approaches in Human Sports Drug Testing 2024/2025
Alongside the considerable advances and accomplishments in drug research and development, the breadth of anti-doping research topics has also continued to grow.
review · 2017
Human sports drug testing by mass spectrometry
Since the installation of anti-doping rules and regulations and their international enforcement in the mid-1960s, mass spectrometry has been an integral part of doping control procedures.
Study · 2016
Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry
The analysis of low-molecular-mass peptides in doping controls has become a mandatory aspect in sports drug testing and, thus, the number of samples that has to be tested for these analytes has been steadily increasing.
animal · 2015
Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model
Background To investigate the effects of AOD9604 intra-articular injections with or without hyaluronic acid (HA) in a collagenase-induced knee osteoarthritis (OA) rabbit model. Design Mature New Zealand white rabbits (n=32) were randomly administered 2 mg collagenase type II twice in each knee joint.